ADAS-cog
Showing 1 - 25 of 717
Alzheimer 3, Epilepsy Trial in Changsha (Lacosamide 100 mg, Levetiracetam 250mg)
Recruiting
- Alzheimer Disease 3
- Epilepsy
- Lacosamide 100 mg
- Levetiracetam 250mg
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Aug 2, 2023
Alzheimer, Early Onset Trial in Japan (LIPUS-Brain, Placebo)
Not yet recruiting
- Alzheimer Disease, Early Onset
- LIPUS-Brain
- Placebo
-
Nagoya, Aichi, Japan
- +11 more
Aug 1, 2023
Mild Cognitive Impairment, Prodromal Alzheimer's Disease Trial (AGB101, Placebo)
Not yet recruiting
- Mild Cognitive Impairment
- Prodromal Alzheimer's Disease
- AGB101
- Placebo
- (no location specified)
Aug 3, 2023
Mild Cognitive Impairment Trial in Quezon (INDAK (Improving Neurocognition through Dance and Kinesthetics), Nutrition
Completed
- Mild Cognitive Impairment
- INDAK (Improving Neurocognition through Dance and Kinesthetics)
- +2 more
-
Quezon, Metro Manila, PhilippinesInstitute for Neurosciences, St. Luke's Medical Center
Oct 26, 2022
Mild Cognitive Impairment Trial in Incheon (ET-101, Sham Device)
Recruiting
- Mild Cognitive Impairment
- ET-101
- Sham Device
-
Incheon, Korea, Republic ofGachon University Gil Medical Center
Jul 3, 2023
Alzheimer's Disease, Dementia, Brain Diseases Trial in Daejeon, Busan, Seoul (ATNC MDD-V1 (Real TMS + Real Cog), ATNC MDD-V1
Recruiting
- Alzheimer's Disease
- +7 more
- ATNC MDD-V1 (Real TMS + Real Cog)
- ATNC MDD-V1 (Sham TMS + Real Cog)
-
Daejeon, Jung-gu, Korea, Republic of
- +2 more
Oct 11, 2023
Alzheimer's Disease Trial in China (50561 high dose, 50561 low dose, Placebo)
Recruiting
- Alzheimer's Disease
- 50561 high dose
- +2 more
-
Beijing, Beijing, China
- +10 more
Apr 11, 2023
Brain Metastases, Radiotherapy Side Effect, Cognitive Impairment Trial in Guangzhou (Monosialotetrahexosyl ganglioside (GM1),
Recruiting
- Brain Metastases
- +4 more
- Monosialotetrahexosyl ganglioside (GM1)
- Control
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 3, 2021
Amnestic Mild Cognitive Impairment Trial in Beijing (multi-domain internet-based adaptive training program, active-control
Recruiting
- Amnestic Mild Cognitive Impairment
- multi-domain internet-based adaptive training program
- active-control program
-
Beijing, ChinaXuanwu Hospital, Capital Medical University
Jul 12, 2022
Mild Dementia, Aging Well Trial in Gainesville (Neurolith Transcranial Pulse Stimulation Active, Neurolith Transcranial Pulse
Not yet recruiting
- Mild Dementia
- Aging Well
- Neurolith Transcranial Pulse Stimulation Active
- Neurolith Transcranial Pulse Stimulation Sham
-
Gainesville, FloridaUniversity of Florida
Jun 14, 2023
Alzheimer, Electric Stimulation Therapy Trial in Beijing (Cortical brain stimulation of mPFC and dlPFC)
Recruiting
- Alzheimer Disease
- Electric Stimulation Therapy
- Cortical brain stimulation of mPFC and dlPFC
-
Beijing, ChinaXuanwu Hospital
Jul 30, 2023
Mild Alzheimer Trial in Seoul (PM012, PM012 Placebo, Donepezil)
Recruiting
- Mild Alzheimer Disease
- PM012
- +3 more
-
Seoul, Seongdon-gu, Korea, Republic ofMediforum
Apr 13, 2023
Mild Cognitive Impairment, Alzheimer Trial in Sacramento, Walnut Creek (Senicapoc, Placebo Tablet)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
- Senicapoc
- Placebo Tablet
-
Sacramento, California
- +1 more
Mar 23, 2022
Alzheimer's Disease (AD) Trial in Worldwide (ABBV-552, Placebo for ABBV-552)
Not yet recruiting
- Alzheimer's Disease (AD)
- ABBV-552
- Placebo for ABBV-552
-
Irvine, California
- +59 more
Mar 6, 2023
Alzheimer Trial in Chaoyang, Beijing (Wei Li Bai capsules, Placebo Comparator of Wei Li Bai capsules)
Recruiting
- Alzheimer Disease
- Wei Li Bai capsules
- Placebo Comparator of Wei Li Bai capsules
-
Chaoyang, Beijing, China
- +2 more
Jan 2, 2023
Alzheimer Trial in São Paulo (Transcranial Pulse Stimulation)
Not yet recruiting
- Alzheimer Disease
- Transcranial Pulse Stimulation
-
São Paulo, SP, BrazilInstituto de Medicina Física e Reabilitação, Hospital das Clínic
Feb 27, 2023
Mild to Moderate Alzheimer's Disease Trial in Beijing, Chongqing (treatment group-Device: NirsCure - Active NirsCure - Active
Enrolling by invitation
- Mild to Moderate Alzheimer's Disease
- treatment group-Device: NirsCure - Active NirsCure - Active settings
- placebo group-Device: NirsCure - Sham NirsCure - Sham settings
-
Beijing, Beijing, China
- +1 more
Aug 18, 2023
Alzheimer Trial in Paris (Placebo, Masitinib (4.5), Standard of care)
Not yet recruiting
- Alzheimer Disease
- Placebo
- +2 more
-
Paris, FranceInstitut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universi
Sep 29, 2022
Alzheimer Trial (RB-ADSC)
Not yet recruiting
- Alzheimer Disease
- RB-ADSC
- (no location specified)
Dec 19, 2022
Ischemic Stroke Trial in Guangzhou (Sodium oligomannate, Placebo capsule)
Not yet recruiting
- Ischemic Stroke
- Sodium oligomannate
- Placebo capsule
-
Guangzhou, Guangdong, ChinaNanfang Hospital,Southern Medical University
Nov 1, 2022